Aetna and Humana to Pull Back on Medicare Advantage Plans
By Nicholas G. Miller
Humana and CVS Health's Aetna will reduce the reach of their Medicare Advantage plans next year as health insurance companies face rising costs.
Aetna said it would offer Medicare Advantage prescription drug plans in 43 states and Washington D.C., one fewer than this year. Humana said it would have Medicare Advantage plans in 46 states and Washington D.C., down from 48 this year.
Aetna's plans will be accessible to 57 million Medicare-eligible beneficiaries, down from 59 million this year. Humana, which currently has Medicare Advantage plans in 89% of counties, will cover only 85% of U.S. counties next year.
Insurers have been pulling back from less profitable Medicare Advantage markets as they face higher utilization of medical services and increased costs as a result. Insurers have claimed that government payments have not kept up with rising costs.
Write to Nicholas G. Miller at nicholas.miller@wsj.com.
(END) Dow Jones Newswires
October 01, 2025 12:32 ET (16:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for October
Undervalued by 15%, This Utilities Stock Could Be an Unexpected AI Winner
The Thrilling 37
The Smartest Moves for Bond Investors Today, and What to Do When You Have Too Many Investments
United States